Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Apr;13(2):182-8.
doi: 10.1111/iwj.12250. Epub 2014 Mar 3.

Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings

Gilbert Hämmerle  1 , Robert Strohal  2
Affiliations
Randomized Controlled Trial

Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings

Gilbert Hämmerle et al. Int Wound J. 2016 Apr.

Abstract

The aim of this study was to determine the efficacy, safety and cost-effectiveness of an octenidine-based wound gel in the treatment of chronic venous leg ulcers. For this purpose, 49 wounds were treated with either modern wound-phase-adapted dressings alone (treatment arm 1; n = 17), octenidine wound gel plus modern wound-phase-adapted dressings (treatment arm 2; n = 17) or octenidine wound gel alone (treatment arm 3; n = 15). During the study period of 42 days with dressing changes every 3-5 days, wound healing characteristics and treatment costs of different dressings were analysed. Wound size reduction was significantly better (P = 0·028) in both octenidine wound gel treatment arms compared to modern dressings alone with total reductions of 14·6%, 64·1% and 96·2% in treatment arms 1-3. Early wound healing was merely observed under octenidine wound gel treatment (n = 9), whereby lowest treatment costs were generated by octenidine wound gel alone (€20·34/dressing change). As a result, the octenidine wound gel is cost-effective and well suitable for the treatment of chronic venous leg ulcers, considering both safety and promotion of wound healing.

Keywords: Chronic venous leg ulcer; Cost-effectiveness; Modern wound dressing; Octenidine wound gel; Wound healing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient distribution and study design.
Figure 2
Figure 2
Reduction of bioburden throughout the course of the study in patients suffering from chronic venous leg ulcers.
Figure 3
Figure 3
Development of granulation tissue throughout the course of the study in patients suffering from chronic venous leg ulcers.
Figure 4
Figure 4
Change in frequency and signs of local infections compared to the prior visit between different treatment arms throughout the course of the study from visits 1–5.
See this image and copyright information in PMC

References

    1. Mekkes JR, Loots MA, van der Wal AC, Bos JD. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003;148:388–401. - PubMed
    1. AWMF Leitlinien. Diagnostik und Therapie des Ulcus cruris venosum [WWW document]. URL http://www.awmf.org/uploads/tx_szleitlinien/037‐009_S3_Diagnostik_und_Th... [accessed on 28 August 2013].
    1. Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic venous leg ulcers: a national clinical guideline [WWW document]. URL http://www.sign.ac.uk/pdf/sign120.pdf [accessed on 28 August 2013].
    1. MedMarket Diligence, LLC. Worldwide Wound Management, 2008–2017. Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan &Rest of World [WWW document]. URL http://mediligence.com/rpt/rpt‐s247.htm [accessed on 28 August 2013].
    1. Leaper D, Münter C, Meaume S, Scalise A, Blanes Mompó N, Petersen Jakobsen B, Gottrup F. The use of biatain Ag in hard‐to‐heal venous leg ulcers: meta‐analysis of randomised controlled trials. PLoS One 2013;8:e67083. - PMC - PubMed

Publication types